Subra
Anand Subra, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20080201174 | PERSONALIZED MEDICAL ADHERENCE MANAGEMENT SYSTEM - Techniques and systems are described hereafter for reducing medical non-adherence by (1) developing the adherence-profile of a member, (2) using the profile to automatically generate a set of interventions, (3) categorizing, prioritizing and selecting the interventions, (4) incorporating the selected interventions into a personalized member user interface page, (5) serving the selected interventions to the member at the appropriate times via multiple channels, (6) observing and measuring member responses, (7) recording member responses in a database and analyzing the responses, (8) adapting the interventions, based on the analysis, to keep the member actively engaged, (9) escalating the interventions if the member response is inadequate, (10) updating the member's adherence profile based on analysis of the database, (11) providing member reports to authorized parties for purposes of paying member incentives, predicting member's utilization of high-cost healthcare services, etc., and (12) providing aggregate de-identified reports for purposes of predicting future risk reserve set asides, drug production and supply chain replenishment requirements. | 08-21-2008 |
20100219097 | UNIFIED INGESTION PACKAGE AND PROCESS FOR PATIENT COMPLIANCE WITH PRESCRIBED MEDICATION REGIMEN - Techniques for reducing non-compliance of medication use are described. The techniques involve generating and storing an identifier for a specific dosage instance of a specific patient, and creating a package that includes a mechanism for conveying the identifier. Once the package is created, a set of one or more medications that are prescribed to be taken by the specific patient at the specific dosage instance are placed in the package. The set of medications within the package in a manner that prevents the identifier from being perceived from the mechanism until the package is opened. Once opened, the identifier is perceived and communicated back to an automated compliance system. | 09-02-2010 |
20140046685 | AUTOMATIC ALERTS BASED ON USER RESPONSE-DOWN TREND LEVELS - A response down-trend level applicable to a user may be determined based on the user's responses to one or more medication reminders. Different levels of the response down-trend may be associated one or more different parties to alert. The particular parties to alert may be determined based upon the current response down-trend level associated with the user. The response-down trend level associated with a user may be determined by calculating a response-down trend value based on the user's responses to one or more medication reminders and comparing the response-down trend value to one or more threshold value of one or more response-down trend levels. In response to determining that a user has reached a particular response-down-trend level, a party associated with the particular response-down-trend level is contacted. | 02-13-2014 |
Frédéric Subra, Paris FR
Patent application number | Description | Published |
---|---|---|
20100216733 | Use of inhibitors and antisense oligonucleotides of btk for treating proliferative mastocytosis - The present invention relates to a method for treating proliferative mastocytosis comprising administering a Bruton tyrosine kinase (BTK) inhibitor, a BTK antisense to a mammal in need of such treatment. The invention is more particularly suited for treating category II, III and IV mastocytosis. | 08-26-2010 |
Frédéric Subra, Paris FR
Patent application number | Description | Published |
---|---|---|
20090286720 | PHARMACEUTICAL COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF A TUMORAL PATHOLOGY COMPRISING AN AGENT MODULATING THE POLYMERIZATION STATE OF ACTIN - A pharmaceutical composition for the treatment, prevention or diagnosis of a tumoral pathology comprising an active agent which stabilizes an actin network of a cellular cytoskeleton. | 11-19-2009 |
20100216733 | Use of inhibitors and antisense oligonucleotides of btk for treating proliferative mastocytosis - The present invention relates to a method for treating proliferative mastocytosis comprising administering a Bruton tyrosine kinase (BTK) inhibitor, a BTK antisense to a mammal in need of such treatment. The invention is more particularly suited for treating category II, III and IV mastocytosis. | 08-26-2010 |
Gilles Subra, Saint Gely Du Fesc FR
Patent application number | Description | Published |
---|---|---|
20110152464 | PIPECOLIC LINKER AND ITS USE FOR CHEMISTRY ON SOLID SUPPORT - The present invention relates to a pipecolic linker and its use as a solid-phase linker in organic synthesis. Said pipecolic solid-phase linker may be used for coupling functional groups chosen between primary amines, secondary amines, aromatic amines, alcohols, phenols and thiols. In particular, said pipecolic solid-phase linker may be used for peptide or pseudopeptide synthesis, such as the reverse N to C peptide synthesis or the retro-inverso peptide synthesis, or for the synthesis of small organic molecules. | 06-23-2011 |
20120070856 | CROSS-LINKING AGENTS - The invention relates to a protein cross-linking agent of the formula, where R | 03-22-2012 |
Gilles Subra, Juvignac FR
Patent application number | Description | Published |
---|---|---|
20080200396 | Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities - The invention relates to a peptide of formula W-DPhe-Arg-Z (I) and to a conjugate thereof of a formula A-W-DPhe-Arg-Z (II), wherein A is a radical corresponding to a nionocarboxylic acid of general formula HOOC—R (III), wherein R is an linear or branched possibly substituted by a hydroxy group aliphatic C | 08-21-2008 |
20110003943 | Supported Oxidation Reactants, Process for their Preparation and Uses Thereof - The present invention relates to a supported oxidation reactant of formula (I): R-[Met(O) | 01-06-2011 |
Laurent Subra, Montgaillard FR
Patent application number | Description | Published |
---|---|---|
20110295036 | METHOD FOR SYNTHESIS OF (1S, 2R)-MILNACIPRAN - The present invention relates to a method for synthesizing a pharmaceutically acceptable acid addition salt of (1S, 2R)-milnacipran comprising the following successive steps: (a) reaction of phenylacetonitrile and of (R)-epichlorhydrin in the presence of a base containing an alkaline metal, followed by a basic treatment, and then by an acid treatment in order to obtain a lactone; (b) reaction of said lactone with MNEt | 12-01-2011 |
Renaud Subra, Dubendorf CH
Patent application number | Description | Published |
---|---|---|
20080196353 | Device For Fixing An Ornamental Profiled Section On A Shaped Band - A device for attaching a profiled trim to a portion of a shaped bead mounted on a glazing, for example mounted on at least part of the periphery of a glazing. The device includes at least one rigid clip including at least an upstream interacting part configured to allow interaction with the shaped bead and a downstream interacting part configured to allow interaction with the profiled trim. The upstream interacting part includes at least one protruding male element or a hollow female element, this element interacting respectively with a corresponding hollow female element or a protruding male element arranged in the shaped bead. The hollow female element has internal dimensions at least partially less than external dimensions of the protruding male element. | 08-21-2008 |
20090291262 | METHOD AND DEVICE FOR PRODUCING A WINDOW GLAZING EQUIPPED WITH A PROFILED STRIP COMPRISING AN INSERT, AND WINDOW GLAZING OBTAINED - A method and a device for mass-production of window glazings using nominal data defining a reference window glazing that is curved, and permissible tolerance bands for these nominal data, in which the mass-produced window glazings are each curved and each includes at least one profiled strip including at least one insert by encapsulation. In a production run, for each window glazing of the production run, at least i) the molding cavity of the mold, or ii) the glazed element, or iii) the insert or inserts, is not of a configuration that corresponds to the dimensions for the reference window glazing. The mass-produced window glazings produced have a curvature that corresponds to that of the reference window glazing within the tolerance bands. | 11-26-2009 |
Renaud Subra, Metz FR
Patent application number | Description | Published |
---|---|---|
20100202824 | CONNECTOR FOR CONNECTING TWO HOLLOW SECTION-PIECE ENDS - Connector ( | 08-12-2010 |
Renaud Subra, Duebendorf CH
Patent application number | Description | Published |
---|---|---|
20100192508 | CONNECTION WITH A CONNECTOR OF TWO HOLLOW ENDS OF PROFILES MADE OF A SYNTHETIC MATERIAL - An association formed from two hollow section ends, the inside of which is based on a plastic that are butted together by a connector, the connector including a body with a central part and two flanges made of plastic that are engaged in the hollow section ends respectively and that have an anchoring mechanism capable of keeping the hollow ends in place around the connector. The anchoring mechanism of the connector is made of plastic and includes at least one element that is flexible and comes into friction contact with the inside of the hollow section ends. | 08-05-2010 |
Sebastien Subra, Meudon FR
Patent application number | Description | Published |
---|---|---|
20150210105 | CARD WITH MARBLED VISUAL EFFECT AND ASSOCIATED MANUFACTURING PROCESS - This invention concerns a card with a marbled visual effect, said card comprising at least one substrate layer comprising a first and a second side, wherein said substrate layer is covered with a translucent protective layer, wherein a pattern cracked by lamination is printed on at least one of the sides of the substrate layer so that the colour located underneath said pattern can be seen through the cracks. | 07-30-2015 |